Press releases
November 14, 2011
Digna Biotech regains all rights to Disitertide (P144) to treat skin conditions
More information
September 21, 2011
FDA Grants Cardiotrophin-1 Orphan Drug Status for Acute Liver Failure Treatment
More information
September 13, 2011
Cardiotrophin 1 shows promising results for treatment of obesity and metabolic syndrome
More information
August 4, 2011
Cardiotrophin-1, a protein that removes fat from adipose tissue and reduces body weight
More information
June 28, 2011
Flamel Technologies and Digna Biotech Announce Multiple Product Development Agreement
More information
March 11, 2011
Cardiotrophin-1 starts a phase I clinical trial in healthy volunteers
More information
February 3, 2011
Digna Biotech and CIMA Receive Euros 1.3 Million Funding for AIPGene Therapy
More information
March 25, 2010 | medio: Press Release
Disitertide (P144), jointly developed by ISDIN and Digna Biotech showed a statistically significant improvement versus placebo in the patients that perceived improvement of the treated skin area affected by systemic sclerosis
More information
January 19, 2010
Digna Biotech starts the clinical research phase with interferon alpha-5 in patients with genotype 1 chronic hepatitis C that have not healed with previous treatment
More information
May 15, 2009 | medio: Press Release
Cardiotrophin-1 showed to improve survival in a rabbit model of fulminant hepatic failure (FHF) of viral origin.
More information
July 28, 2008
Biotecnol and Digna Biotech extend their existing collaboration on the development of Cardiotrophin-1 through an exclusive marketing, promotion and option agreement
More information
May 8, 2008
Digna Biotech and Aachen Resonance signed an agreement for the joint development of drug eluting devices.
More information
October 23, 2007
Digna Biotech obtains the financial support of Clave Mayor and Suan Farma Biotech for the clinical development of the Cardiotrophine-1
More information
May 21, 2007
Biotecnol and Digna Biotech to collaborate on the development of Cardiotrophin-1 for organ transplantation
More information
December 19, 2006
Digna and Ferrer get an agreement to comercialize a new diagnostic test to detect the thrombotic risk
More information
